No Data
Veracyte Insider Sold Shares Worth $908,923, According to a Recent SEC Filing
Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Morgan Stanley Raises Price Target on Veracyte to $48 From $40, Keeps Underweight Rating
Cathie Wood's Ark Invest Weekly Recap: Boosts AI and Crypto Bets, Trims Palantir, GitLab, and AMD
Cathie Wood's Ark Invest Recap: Pivots to AI Drug Discovery, Gene Editing Stocks, Reduces Diagnostics and Software Exposure